Medicare National Coverage Determinations (NCD) Manual (Pub. 100-03), Ch. 1 § 50.7

Cochleostomy With Neurovascular Transplant for Meniere’s

Last amended: 2003Year: 2003Length: 95 wordsOfficial source
50.7 - Cochleostomy With Neurovascular Transplant for Meniere’s Disease (Rev. 1, 10-03-03) CIM 35-50 Not Covered Meniere’s disease (or syndrome) is a common cause of paroxysmal vertigo. Meniere’s syndrome is usually treated medically. When medical treatment fails, surgical treatment may be required. While there are two recognized surgical procedures used in treating Meniere’s disease (decompression of the endolymphatic hydrops and labyrinthectomy), there is no scientific evidence supporting the safety and effectiveness of cochleostomy with neurovascular transplant in treatment of Meniere’s syndrome. Accordingly, Medicare does not cover cochleostomy with neurovascular transplant for treatment of Meniere’s disease.
Medicare National Coverage Determinations (NCD) Manual (Pub. 100-03), Ch. 1 § 50.7: Cochleostomy With Neurovascular Transplant for Meniere’s | Justis AI